SCHEMBL18156645

SCHEMBL18156645

CCCC1CCC(c2ccc(-c3cc(F)c(C(F)(F)Oc4cc(F)c(F)c(F)c4C)c(F)c3)cc2)OC1

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FASN P49327 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19679589 0.95 FASN (0.34) FASN
SCHEMBL19679585 0.94 FASN (0.39) FASN
SCHEMBL19679590 0.94 FASN (0.34) FASN
SCHEMBL18156626 0.93 FASN (0.31) FASN
SCHEMBL19679588 0.90 FASN (0.31) FASN
SCHEMBL21567705 0.88 FASN (0.38) FASN
SCHEMBL12929166 0.88 FASN (0.42) FASN
SCHEMBL18156612 0.88
SCHEMBL16572425 0.87 FASN (0.42) FASN
SCHEMBL19679592 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190345387-A1 LIQUID-CRYSTAL COMPOSITION AND LIQUID-CRYSTAL DISPLAY DEVICE EMPLOYING THE SAME DAXIN MATERIALS CORPARATION (TW) 2019-11-14 US disclosed
US-20170349831-A1 LIQUID CRYSTAL COMPOUND CONTAINING DIFLUORMETHOXY BRIDGE, COMPOSITION AND APPLICATION THEREOF BEIJING BAYI SPACE LCD TECHNOLOGY CO., LTD. (CN) 2017-12-07 US disclosed
US-20170349831-A1 LIQUID CRYSTAL COMPOUND CONTAINING DIFLUORMETHOXY BRIDGE, COMPOSITION AND APPLICATION THEREOF BEIJING BAYI SPACE LCD TECHNOLOGY CO., LTD. (CN) 2017-12-07 US disclosed
US-9783735-B2 Liquid crystal display device and liquid crystal composition used therefor SAMSUNG DISPLAY CO., LTD. (KR) 2017-10-10 US disclosed
US-9783735-B2 Liquid crystal display device and liquid crystal composition used therefor SAMSUNG DISPLAY CO., LTD. (KR) 2017-10-10 US disclosed
EP-3222696-A2 LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL COMPOSITION USED THEREFOR Samsung Display Co., Ltd. (KR) 2017-09-27 EP disclosed
US-20160304783-A1 LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL COMPOSITION USED THEREFOR DONGJIN SEMICHEM CO., LTD. (KR) 2016-10-20 US disclosed
US-20160304783-A1 LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL COMPOSITION USED THEREFOR DONGJIN SEMICHEM CO., LTD. (KR) 2016-10-20 US disclosed
EP-3081621-A2 LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL COMPOSITION USED THEREFOR Samsung Display Co., Ltd. (KR) 2016-10-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304783-A1 LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL COMPOSITION USED THEREFOR SLC39A11, CYP4F11, WEE1 FASN 2164/4885
US-20170349831-A1 LIQUID CRYSTAL COMPOUND CONTAINING DIFLUORMETHOXY BRIDGE, COMPOSITION AND APPLICATION THEREOF PLD1, CCND1, LPCAT1 FASN 1358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.